Home > Share Market > Stocks > Vivimed labs > Financial Statements > VIVIMEDLAB Key Financial Ratios

Vivimed labs Financial Statements

Vivimed labs Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2018 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Revenue growth (19) 8.64 (2.50) 2.17
Op profit growth (47) 73.40 7.01 5.77
EBIT growth (53) 94.10 15.90 6.40
Net profit growth (64) 156 16.10 8.52
Profitability ratios (%)        
OPM 17.90 27.50 17.20 15.70
EBIT margin 13.90 24.10 13.50 11.30
Net profit margin 6.57 14.60 6.22 5.22
RoCE 8.68 21.40 11.60 10.20
RoNW 1.99 8.11 3.66 3.22
RoA 1.02 3.25 1.34 1.18
Per share ratios ()        
EPS 9.22 26.40 51.60 44.50
Dividend per share 0.40 0.40 -- --
Cash EPS 2.61 19.20 13.70 3.62
Book value per share 149 90.60 361 345
Valuation ratios        
P/E 7.71 4.03 1.61 1.65
P/CEPS 27.20 5.54 6.05 20.30
P/B 0.65 1.17 0.26 0.24
EV/EBIDTA 5.92 4.43 6.56 7.10
Payout (%)        
Dividend payout 4.24 1.53 -- --
Tax payout (11) (25) (16) (7.10)
Liquidity ratios        
Debtor days 73.20 65.70 88.90 89.60
Inventory days 158 123 127 116
Creditor days (71) (59) (58) (59)
Leverage ratios        
Interest coverage (2.10) (5.30) (2.20) (2)
Net debt / equity 0.59 1.30 1.57 1.76
Net debt / op. profit 3.42 2.37 3.96 4.54
Cost breakup ()        
Material costs (40) (37) (46) (47)
Employee costs (17) (13) (13) (13)
Other costs (25) (23) (23) (24)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000